CLINICAL TRIALS PROFILE FOR EDECRIN
✉ Email this page to a colleague
All Clinical Trials for EDECRIN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02852564 ↗ | Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection | Completed | University of Kansas Medical Center | Phase 1 | 2016-08-01 | Phase 1 study to provide quantitative characterization of the renal elimination of ethacrynic acid and metabolites in patients with non-muscle invasive bladder cancer (NMIBC) at the time of transurethral resection of bladder tumor |
NCT02852564 ↗ | Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection | Completed | Eugene Lee, MD | Phase 1 | 2016-08-01 | Phase 1 study to provide quantitative characterization of the renal elimination of ethacrynic acid and metabolites in patients with non-muscle invasive bladder cancer (NMIBC) at the time of transurethral resection of bladder tumor |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for EDECRIN
Condition Name
Clinical Trial Locations for EDECRIN
Trials by Country
Clinical Trial Progress for EDECRIN
Clinical Trial Phase
Clinical Trial Sponsors for EDECRIN
Sponsor Name